IPG Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

IPG Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-674	Closed	-$376K	–	152
2021 Q2	$376K	Buy	+674	New	+$341K	0.11%	97
2017 Q1	–	Sell	-2,650	Closed	-$973K	–	147
2016 Q4	$973K	Buy	+2,650	New	+$1.01M	0.4%	51
2016 Q3	–	Sell	-2,600	Closed	-$908K	–	133
2016 Q2	$908K	Buy	+2,600	New	+$1M	0.38%	50
2016 Q1	–	Sell	-600	Closed	-$326K	–	129
2015 Q4	$326K	Buy	+600	New	+$325K	0.15%	82
2015 Q3	–	Sell	-1,200	Closed	-$612K	–	141
2015 Q2	$612K	Buy	+1,200	New	+$586K	0.22%	77

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

IPG Investment Advisors's REGN Position: Q3 2021 in Review

IPG Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 674 shares — an estimated $376K sold.

IPG Investment Advisors first reported a position in REGN in Q2 2015 and held it in 5 quarters. The position peaked at $973K in Q4 2016. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

IPG Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
IPG Investment Advisors sold 674 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $376K.
IPG Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 5 quarters.
IPG Investment Advisors's Regeneron Pharmaceuticals position peaked at $973K in Q4 2016.
1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on IPG Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.